Skip to main content

Retraction Note to: Targeting MALAT1 and miRNA-181a-5p for the intervention of acute lung injury/acute respiratory distress syndrome

The Original Article was published on 06 January 2021

Retraction to: Respir Res (2021) 22:1 https://doi.org/10.1186/s12931-020-01578-8

The Editor-in-Chief has retracted this Article. After publication, concerns were raised regarding the methodology and data presented, specifically:

  • The source of primary HPMECs is incorrectly stated as ATCC, and the cell culture conditions described in the Methods are unsuitable for primary cells.

  • The flow cytometry assay described in the Methods does not match the presented data.

  • The same western blot control bands are used in Figs. 2 and 3, and in Figs. 4 and 5.

The authors have provided raw flow cytometry data, which is inconsistent with the results presented in the Article and contains duplication between various samples. The authors have been unable to provide full uncropped western blot gel images for verification upon the Editors' request. Additionally, the Article was simultaneously submitted to and published by another journal [1, retracted]. The Editor-in-Chief therefore no longer has confidence in the presented data and the originality of this work.

All authors agree to this retraction.

Reference

  1. Liu Y, Wang X, Li P, Zhao Y, Yang L, Yu W, Xie H. RETRACTED: Targeting MALAT1 and miRNA-181a-5p for the intervention of acute lung injury/acute respiratory distress syndrome [retracted in: _Respir. Med._ 2021 Nov;188:106601]. Respir Med. 2021;22:1. https://doi.org/10.1016/j.rmed.2020.106210.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Weifeng Yu or Hong Xie.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Liu, Y., Wang, X., Li, P. et al. Retraction Note to: Targeting MALAT1 and miRNA-181a-5p for the intervention of acute lung injury/acute respiratory distress syndrome. Respir Res 23, 170 (2022). https://doi.org/10.1186/s12931-022-02066-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12931-022-02066-x